Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Leukemia, Promyelocytic, Acute 5Myelodysplastic Syndromes 3Leukemia, Myeloid, Acute 3Leukemia 3Small Cell Lung Carcinoma 2Melanoma 2Prostatic Neoplasms 1Primary Myelofibrosis 1Multiple Myeloma 1Lung Neoplasms 1Hematologic Neoplasms 1Childhood Acute Promyelocytic Leukemia With PML-RARA 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Adenoid Cystic 1Adenocarcinoma of Lung 1

Interventions

pembrolizumab 3Axitinib 2regorafenib 1avelumab 1amivantamab 1Tretinoin 1Specimen Handling 1Radiation 1Pemetrexed 1Nelfinavir 1Magnetic Resonance Spectroscopy 1Glutamate Carboxypeptidase II 1GSK-3326595 1Etoposide 1Endoscopic Mucosal Resection 1Doxorubicin 1Cisplatin 1Bortezomib 14-amino-5-fluoro-3-(5-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl)quinolin-2(1H)-one 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Carcinoma, Adenoid Cystic × Tretinoin × Clear all
NCT03999684 2023-01-23

A Trial of All-trans Retinoic Acid (ATRA) in Advanced Adenoid Cystic Carcinoma

Dana-Farber Cancer Institute

Phase 2 Completed
18 enrolled 8 charts

Carcinoma, Adenoid Cystic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡